Therapeutic effect of ulinastatin vs gabexate mesilate in management of acute pancreatitis

World Chinese Journal of Digestology

Volumn 21, Issue 14, 2013, Pages 1339-1342

  Bai, Yi Tong ^a   Guo, Xiao Zhong ^a   Li, Hong Yu ^a   Shao, Xiao Dong ^a   Cui, Zhong Min ^a   Wang, Di ^a   Zhao, Jia Jun ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Acute pancreatitis; Gabexate mesilate; Ulinastatin

Indexed keywords

AMYLASE; GABEXATE MESILATE; GLUCOSE; TRIACYLGLYCEROL LIPASE; ULINASTATIN;

ACUTE PANCREATITIS; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; GLOMERULUS FILTRATION RATE; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PANCREATITIS;

EID: 84940355772     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v21.i14.1339     Document Type: Article

References (3)

1. Koizumi R, Kanai H, Maezawa A, Kanda T, Nojima Y, Naruse T. Therapeutic effects of ulinastatin on experimental crescentic glomerulonephritis in rats. Nephron 2000; 84: 347-353 [PMID: 10754412 DOI: 10.1159/000045610]
2. Aosasa S, Ono S, Mochizuki H, Tsujimoto H, Ueno C, Matsumoto A. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock 2001; 15: 101-105 [PMID: 11220636 DOI: 10.1097/00024382-200115020-00004]
3. Kast RE. Ritonavir and disulfiram may be synergistic in lowering active interleukin-18 levels in acute pancreatitis, and thereby hasten recovery. JOP 2008; 9: 350-353 [PMID: 18469453]